Investigating The effect of melatonin on serum changes of Adropin in patients with diabetic retinopathy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211222053481N1

Enrollment

Registered

2022-02-17

Start date

2022-02-20

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy. Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy

Interventions

Intervention 1: Intervention group: Diabetic patients with retinopathy. In this study, a total of 44 patients with diabetic retinopathy aged 65 to 75 years who are referred to Nikokary hospital is sel

Eligibility

Sex/Gender

All

Age

65 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with diabetic retinopathy Patients without a history of melatonin use Age range 65 to 75 years

Exclusion criteria

Exclusion criteria: History of melatonin use History of using antioxidant compounds such as doxium Has not consumed the essential elements with antioxidant properties Antioxidant vitamins such as vitamins C and E.Not consumed

Design outcomes

Primary

Measure	Time frame
Serum changes of Adropin. Timepoint: Measurement of serum Adropin levels before intervention and 60 days after melatonin administration. Method of measurement: ELISA Method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Javadzadeh

Tabriz University of Medical Sciences

javadzadeha@tbzmed.ac.ir+98 41 3442 6078

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026